checkpoint inhibitors
Combined Dostarlimab, Standard of Care Improves Survival for Endometrial Cancer Patients
Adding the PD-1 checkpoint inhibitor Jemperli to carboplatin and paclitaxel improves survival in patients with ...
MAY 13, 2023

Pharmacokinetics May Help Optimize Dosing of ICIs
Flat and extended-interval dosing of some immune checkpoint inhibitor (ICI) drugs can be used in certain ...
APRIL 14, 2022

Are We Hitting the Mark With PD-L1 Biomarker Tests?
Potential hyperprogression and decreased survival in some patients taking checkpoint inhibitors, combined with ...
AUGUST 7, 2018

Checkpoint Inhibitor AEs Checked With Steroids
To manage the immune-related adverse events of checkpoint inhibitors—particularly those caused by ...
MAY 18, 2018
